BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12649119)

  • 1. L-Asparaginase-associated hyperlipidemia with hyperviscosity syndrome in a patient with T-cell lymphoblastic lymphoma.
    Meyer B; Hagen W; Scheithauer W; Ohler L; Kornek GV
    Ann Oncol; 2003 Apr; 14(4):658-9. PubMed ID: 12649119
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudohyponatraemia due to L-asparaginase-associated dyslipidaemia in T-cell lymphoblastic lymphoma.
    Kothari J; Thomas A; Goldstone A
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24686801
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-asparaginase-induced hyperlipidemia in a case of acute lymphoblastic leukemia].
    Konya H; Tamura S; Miyazaki E; Inoue N; Okamoto T; Takemoto Y; Kohsaki M; Kanemaru A; Kakishita E
    Rinsho Ketsueki; 1991 Mar; 32(3):250-4. PubMed ID: 2041167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphoma.
    Heenan JM; Hooper AJ; Burnett JR; Cooney J
    Pathology; 2021 Dec; 53(7):924-926. PubMed ID: 34049714
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid and asparaginase-induced hyperlipidemia in leukemia.
    Abramson DH; Servodidio CA; Steinherz PG; Lee T
    Insight; 1995 Apr; 20(1):12-3. PubMed ID: 7616065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with L-asparaginase and prednisone.
    Athanassiadou F; Kourti M; Papageorgiou T; Stamou M; Makedou A; Boufidou A
    Pediatr Int; 2004 Dec; 46(6):743-4. PubMed ID: 15660880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transient hyperlipidemia secondary to treatment with asparaginase and prednisone].
    Losa Frías V; Martín-Sacristán Martín B; Díaz Conejo R; Ramos Corral R; Velasco Arribas MR
    An Pediatr (Barc); 2010 Jan; 72(1):85-7. PubMed ID: 19879821
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid function is not affected by second exposure to erwinia asparaginase for childhood acute lymphoblastic leukemia.
    Bossi G; Larizza D; Conter V
    Haematologica; 1997; 82(4):507-8. PubMed ID: 9299875
    [No Abstract]   [Full Text] [Related]  

  • 9. L-asparaginase induced acute parotitis during intensification therapy of acute lymphoblastic leukemia.
    Kathwate J; Mundada S; Patil P
    Indian J Cancer; 2014; 51(4):537. PubMed ID: 26842187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of Erwinia-asparaginase after anaphylactic reaction to Peg-asparaginase].
    Viña Romero MM; García Gil S; Nazco Casariego GJ; Merino Alonso J; Gutiérrez Nicolás F
    An Pediatr (Engl Ed); 2019 Mar; 90(3):187-188. PubMed ID: 29705180
    [No Abstract]   [Full Text] [Related]  

  • 11. L-asparaginase induced hyperlipidaemia in acute lymphoblastic leukaemia.
    Nesheli HM; Tamaddoni A; Nesheli MM; Yahyai A; Khabiri F; Hosseinzadeh F; Moghaddam TG
    J Pak Med Assoc; 2013 Mar; 63(3):324-6. PubMed ID: 23914630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experience with plasma exchange treatment of acute lymphoblastic leukemia in a case with fulminant hepatitis related to L-asparaginase.
    Bilgir O; Calan M; Bilgir F; Cagliyan G; Arslan O
    Transfus Apher Sci; 2013 Oct; 49(2):328-30. PubMed ID: 23871581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
    Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
    Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
    [No Abstract]   [Full Text] [Related]  

  • 14. [The adverse reaction of L-asparaginase and its prevention].
    Lai YH; Wu ZL; Chen FX
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):533-4. PubMed ID: 16083559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in researches on L-asparaginase targeted to childhood leukemia].
    Cui YQ; Chen FX; Wu ZL
    Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):227-30. PubMed ID: 15144726
    [No Abstract]   [Full Text] [Related]  

  • 16. [Distal coronary thrombosis during L-asparaginase treatment for an acute lymphoblastic leukaemia].
    Fraison JB; Calvet P; Domnisoru I; Altamiranda S; Vernhet-Kovacsik H; Saad A; Gallay P; Reny JL; Berdague P
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):303-5. PubMed ID: 21663890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase.
    Steinherz PG
    Cancer; 1994 Dec; 74(12):3234-9. PubMed ID: 7982187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis as treatment for transient iatrogenic severe hyperlipidemia in a child with leukemia.
    Kropshofer G; Wehl G; Högler W; Meister B; Heitger A; Nussbaumer W
    Med Pediatr Oncol; 2003 Aug; 41(2):177. PubMed ID: 12825232
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity.
    Hoogerbrugge N; Jansen H; Hoogerbrugge PM
    Leukemia; 1997 Aug; 11(8):1377-9. PubMed ID: 9264396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
    Chiewchengchol D; Wananukul S; Noppakun N
    Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.